These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 18035435)

  • 1. Clinical implications of the effects of non-ionic radiocontrast medium exposure on microalbuminuria in patients undergoing coronary angiography.
    Celik T; Iyisoy A; Kardesoglu E; Isik E
    Int J Cardiol; 2009 Feb; 132(1):148-9. PubMed ID: 18035435
    [No Abstract]   [Full Text] [Related]  

  • 2. Negligible effect of non-ionic radiocontrast medium exposure on microalbuminuria in patients undergoing coronary angiography.
    Chu CS; Cheng KH; Lee KT; Lin TH; Voon WC; Tsai LY; Sheu SH; Lai WT
    Int J Cardiol; 2009 Feb; 132(1):150-1. PubMed ID: 18182171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of microalbuminuria after non-ionic radiocontrast medium exposure in patients undergoing coronary angiography.
    Cheng KH; Chu CS; Lee KT; Lin TH; Voon WC; Tsai LY; Sheu SH; Lai WT
    Int J Cardiol; 2008 Jun; 127(1):126-8. PubMed ID: 17537532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetylcysteine and sodium bicarbonate versus N-acetylcysteine and standard hydration for the prevention of radiocontrast-induced nephropathy following coronary angiography.
    Schmidt P; Pang D; Nykamp D; Knowlton G; Jia H
    Ann Pharmacother; 2007 Jan; 41(1):46-50. PubMed ID: 17190844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Contrast-media-induced nephrotoxicity].
    Adolph E; Chatterjee T; Ince H; Eckard H; Rehders T; Kische S; Drawert S; Petzsch M; Nienaber CA
    Dtsch Med Wochenschr; 2005 Oct; 130(42):2391-6. PubMed ID: 16235148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast nephropathy in high-risk patients undergoing coronary angiography and intervention.
    Uddin MA; Rabbani MA; Jafary FH; Bhatti MA; Islam M
    J Coll Physicians Surg Pak; 2005 Dec; 15(12):791-4. PubMed ID: 16398973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic hemodialysis for the prevention of contrast-induced nephropathy after coronary angiography.
    Marenzi G
    Nat Clin Pract Nephrol; 2008 Mar; 4(3):130-1. PubMed ID: 18059387
    [No Abstract]   [Full Text] [Related]  

  • 8. Advances in contrast media and contrast injectors.
    Messenger JC; Casserly IP
    Cardiol Clin; 2009 Aug; 27(3):407-15. PubMed ID: 19573714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
    Oldemeyer JB; Biddle WP; Wurdeman RL; Mooss AN; Cichowski E; Hilleman DE
    Am Heart J; 2003 Dec; 146(6):E23. PubMed ID: 14661012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ameliorating contrast-induced nephropathy.
    Ramanathan K; Webb J
    J Invasive Cardiol; 2001 Nov; 13(11):741. PubMed ID: 11689717
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiocontrast media nephrotoxicity. Clinical aspects.
    Arrigo G; Cavaliere G; Scalia A; Schiavina G; D'Amico G
    Contrib Nephrol; 1987; 55():176-84. PubMed ID: 3549149
    [No Abstract]   [Full Text] [Related]  

  • 12. [Review of the radiocontrast nephropathy risk profiles and risk stratification].
    Toprak O; Cirit M; Bayata S; Yeşil M
    Anadolu Kardiyol Derg; 2004 Dec; 4(4):331-5. PubMed ID: 15590363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a rapid intra-arterial infusion of dextrose 5% prior to coronary angiography on frequency of contrast-induced nephropathy in high-risk patients.
    Clavijo LC; Pinto TL; Kuchulakanti PK; Torguson R; Chu WW; Satler LF; Kent KM; Suddath WO; Waksman R; Pichard AD
    Am J Cardiol; 2006 Apr; 97(7):981-3. PubMed ID: 16563900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.
    Cavusoglu E; Chhabra S; Marmur JD; Kini A; Sharma SK
    Minerva Cardioangiol; 2004 Oct; 52(5):419-32. PubMed ID: 15514576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nephropathy, clinical aspects and prevention].
    Bahner ML
    Dtsch Med Wochenschr; 2006 May; 131(18):1050; author reply 1051. PubMed ID: 16673234
    [No Abstract]   [Full Text] [Related]  

  • 16. Cystatin C and creatinine as markers for radiocontrast-induced nephropathy in patients treated with N-acetylcysteine.
    Merkle M; Sauter M; Argirov M; Wörnle M
    Ren Fail; 2010 Jan; 32(1):85-90. PubMed ID: 20113272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial.
    Ozcan EE; Guneri S; Akdeniz B; Akyildiz IZ; Senaslan O; Baris N; Aslan O; Badak O
    Am Heart J; 2007 Sep; 154(3):539-44. PubMed ID: 17719303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose effect of nitrendipine on urinary enzymes and microproteins following non-ionic radiocontrast administration.
    Carraro M; Mancini W; Artero M; Stacul F; Grotto M; Cova M; Faccini L
    Nephrol Dial Transplant; 1996 Mar; 11(3):444-8. PubMed ID: 8671813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemofiltration and the prevention of radiocontrast-agent-induced nephropathy.
    Forman JP
    N Engl J Med; 2004 Feb; 350(8):836-8; author reply 836-8. PubMed ID: 14978836
    [No Abstract]   [Full Text] [Related]  

  • 20. [Creatinine clearance and contrast nephropathy in patients with normal creatinine levels].
    de Agustín JA; Carda R; Manzano Mdel C; Ruiz-Mateos B; García-Rubira JC; Fernández-Ortiz A; Vilacosta I; Macaya C
    Rev Esp Cardiol; 2007 Jul; 60(7):772-6. PubMed ID: 17663862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.